Adverum Biotechnologies Inc (ADVM)
7.53
+0.12
(+1.62%)
USD |
NASDAQ |
Nov 04, 16:00
7.53
0.00 (0.00%)
After-Hours: 20:00
Adverum Biotechnologies Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -807.1% |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | -379.1% |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | -6.45K% |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | -22.37K% |
September 30, 2018 | -2.52K% |
Date | Value |
---|---|
June 30, 2018 | -3.82K% |
March 31, 2018 | -7.96K% |
December 31, 2017 | -3.21K% |
September 30, 2017 | -2.99K% |
June 30, 2017 | -2.47K% |
March 31, 2017 | -3.48K% |
December 31, 2016 | -4.59K% |
September 30, 2016 | -3.62K% |
June 30, 2016 | -20.08K% |
March 31, 2016 | -5.81K% |
December 31, 2015 | -1.47K% |
September 30, 2015 | -1.48K% |
June 30, 2015 | -4.81K% |
March 31, 2015 | -4.68K% |
December 31, 2014 | -5.12K% |
September 30, 2014 | -4.05K% |
June 30, 2014 | -3.77K% |
March 31, 2014 | -5.54K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-807.1%
Minimum
Mar 2023
-379.1%
Maximum
Mar 2021
-593.1%
Average
-593.1%
Median
Profit Margin (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | -325.3% |
Cassava Sciences Inc | -- |
Regenxbio Inc | -237.7% |
Editas Medicine Inc | -13.18K% |
Apellis Pharmaceuticals Inc | -18.86% |